Real Brands Inc
OTC:RLBD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Real Brands Inc
OTC:RLBD
|
US |
|
Northern Data AG
XETRA:NB2
|
DE |
|
Profarma Distribuidora de Produtos Farmaceuticos SA
BOVESPA:PFRM3
|
BR |
|
A
|
Amulaire Thermal Technology Inc
TWSE:2241
|
TW |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of RLBD.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
RLBD Competitors Multiples
Real Brands Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Real Brands Inc
OTC:RLBD
|
27k USD | 0.1 | -0 | -1.8 | -1.6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
900.7B USD | 13.8 | 43.6 | 29.4 | 31.4 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
581B USD | 6.2 | 21.7 | 15.1 | 18.5 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
236B GBP | 5.3 | 30.3 | 16.8 | 23.6 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.4 | 11.5 | 13 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
304.8B USD | 4.7 | 16.7 | 10.3 | 12.6 | |
| CH |
|
Novartis AG
SIX:NOVN
|
232.5B CHF | 5.1 | 20.7 | 12.8 | 16.5 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.2 | 7.6 | 8.9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
156.2B USD | 2.5 | 20.1 | 7.7 | 10.3 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
119.2B USD | 2.5 | 16.9 | 7.1 | 8.8 |